Literature DB >> 34560536

Gestational diabetes mellitus - A metabolic and reproductive disorder.

Abbas Alam Choudhury1, V Devi Rajeswari2.   

Abstract

Maternal health associated with Gestational Diabetes Mellitus (GDM) has been gaining significant research attention due to its severe risk and adverse health effects. GDM is the leading health disease in pregnant women. It is the most common metabolic disease and it can affect up to 25% of women during pregnancy. Pregnancy is a sensitive period that impacts both pregnant women and their unborn children's long-term health. It is a well-known fact that the leading causes of disease and mortality worldwide are diabetes mellitus and cancer, and specifically, women with diabetes mellitus are at a higher risk of developing breast cancer (BC). Women who have diabetes are equally vulnerable to reproductive diseases. Reproductive dysfunctions with diabetes are mainly attributed to coexisting polycystic ovarian syndrome (PCOS), obesity, and hyperinsulinemia, etc. Moreover, India has long been recognized as the world's diabetic capital, and it is widely acknowledged that particularly pregnant and lactating women are among the most affected by diabetes. In India, one-third (33%) of women with GDM had a history of maternal diabetes. Nevertheless, the latest research suggests that gestational diabetes is also a risk factor for cardiometabolic diseases of the mother and offspring. Therefore, in the 21st century, GDM imposes a major challenge for healthcare professionals. We intend to explore the role of diabetes on female reproductive function throughout various stages of life in the perspective of the changing prognosis, prevalence, and prevention of GDM.
Copyright © 2021. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Diabetes; Gestational; Hyperinsulinemia; Pregnancy; Reproductive

Mesh:

Substances:

Year:  2021        PMID: 34560536     DOI: 10.1016/j.biopha.2021.112183

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Signaling Pathways in Pregnancy.

Authors:  Giovanni Tossetta; Daniela Marzioni
Journal:  Cells       Date:  2022-04-20       Impact factor: 7.666

2.  A self-efficacy-enhancing physical activity intervention in women with high-risk factors for gestational diabetes mellitus: study protocol for a randomized clinical trial.

Authors:  Xiao Yang; Ji Zhang; Xiangzhi Wang; Yi Xu; Li Sun; Yingli Song; Ruijuan Bai; Hui Huang; Jing Zhang; Ruixing Zhang; Erfeng Guo; Lingling Gao
Journal:  Trials       Date:  2022-06-06       Impact factor: 2.728

3.  Increased Central and Peripheral Thyroid Resistance Indices During the First Half of Gestation Were Associated With Lowered Risk of Gestational Diabetes-Analyses Based on Huizhou Birth Cohort in South China.

Authors:  Zhao-Min Liu; Guoyi Li; Yi Wu; Di Zhang; Sujuan Zhang; Yuan-Tao Hao; Weiqing Chen; Qi Huang; Shuyi Li; Yaojie Xie; Mingtong Ye; Chun He; Ping Chen; Wenjing Pan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-08       Impact factor: 5.555

4.  Alleviation of Myocardial Inflammation in Diabetic Rats by Flavonoid Extract of Helichrysum Arenarium and Its Effect on Damaged Myocardial Cells Induced by High Glucose.

Authors:  Huanyu Liu; Wei Lan
Journal:  Front Surg       Date:  2022-04-14

Review 5.  Serine Hydrolases in Lipid Homeostasis of the Placenta-Targets for Placental Function?

Authors:  Natascha Berger; Hanna Allerkamp; Christian Wadsack
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

Review 6.  A Big Role for microRNAs in Gestational Diabetes Mellitus.

Authors:  Matladi Masete; Stephanie Dias; Nompumelelo Malaza; Sumaiya Adam; Carmen Pheiffer
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-25       Impact factor: 6.055

7.  History of Endometriosis Is Independently Associated with an Increased Risk of Ovarian Cancer.

Authors:  Antonio Sarría-Santamera; Zaukiya Khamitova; Arnur Gusmanov; Milan Terzic; Mar Polo-Santos; Miguel A Ortega; Angel Asúnsolo
Journal:  J Pers Med       Date:  2022-08-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.